⭐ Top Story

📈 Top Movers

📰 Today's News

🌿

From the Village Green

Daily curated intelligence from social media — cannabis market trends, breaking news, regulatory updates & M&A signals

🌿 Village Green

Friday, May 16, 2026 | 7:30 AM ET | Curated by Sheeba

Curated from social media posts and threads across Twitter/X, Reddit, and LinkedIn

Vireo Growth Dominates May M&A: Four Deals Close, Fifth Announced

Vireo Growth closes four transactions in six weeks, building footprint of 160+ dispensaries across 10 states. Strategic consolidation positions MSO as major player ahead of federal rescheduling.

Read more →

Cannabist Files Chapter 15: Once-Marquee MSO Exits Multiple Markets

Cannabist bankruptcy filing accelerates market consolidation. Company selling Ohio and Delaware permits for $63.5M combined; Virginia exit closed in February for $130M. Signals MSO weakness amid rescheduling transition.

Read more →

High Tide’s Remexian Wins Dual Court Victories in German Market

High Tide’s recently acquired German subsidiary, Remexian Pharma, secures court wins against competitors in thriving German medical cannabis market. €27.2M investment paying dividends in international expansion strategy.

Read more →

DEA Schedules Marijuana Rescheduling Hearing for June 29, 2026

Justice Department announces new administrative hearing starting June 29 to resolve marijuana rescheduling. Federal Register notice published to govern proceedings. Major regulatory milestone on horizon.

Read more →

DOJ Rescheduling Order: Limited Medical Cannabis Relief, Not Full Legalization

Trump administration’s partial rescheduling eases specific regulatory burdens for medical cannabis but leaves broader legal framework unchanged. State-legal industry remains non-compliant federally despite easing pressure.

Read more →

Congress Fractures Over Rescheduling: Republicans Attempt to Block

GOP Senator Jim Banks urges Indiana Governor not to legalize despite federal rescheduling. Congressional report details limitations of rescheduling. Federal-state policy tension continues even as rescheduling proceeds.

Read more →

Georgia Governor Expands Medical Marijuana Access: Vaping Permitted, New Conditions

Georgia’s executive action adds vaping as delivery method, expands qualifying conditions, and changes THC potency limits. State-level expansion continues despite federal rescheduling debate. Growing medical market opportunity.

Read more →

ATF Updates Gun Form to Recognize Medical Marijuana’s Legal Status

Federal agency adjusts form acknowledging medical marijuana’s federally legal status under Trump rescheduling. Administrative harmonization signals regulatory acceptance of partial rescheduling framework.

Read more →

California Study: Cannabis Shows Potential for Obesity & Diabetes Treatment

New research from California finds evidence cannabis could treat obesity and diabetes. Broadens therapeutic use case beyond traditional pain/anxiety indications. Potential catalyst for medical cannabis expansion.

Read more →

Congress Presses Trump for Complete Reform Beyond Rescheduling

Members of Congress and activists highlight need for comprehensive marijuana policy reform beyond incremental rescheduling. Message: partial measures insufficient to resolve federal-state conflict. Pressure building for full legalization.

Read more →

France CBD Edibles Ban Takes Effect May 15: Regulatory Crackdown

France implements sweeping CBD edibles ban effective May 15, 2026. European regulatory crackdown signals tightening restrictions on hemp-derived cannabinoid products across international markets.

Read more →

Switzerland’s Lausanne Pilot: Legal Market Cuts Consumption 20%, Impacts Black Market

Cann-L pilot project in Lausanne shows 20% consumption reduction and significant black market revenue loss. Evidence-based framework suggests regulated legal markets protect youth while reducing illicit competition.

Read more →

📰 Village Green | Daily Cannabis Industry Intelligence

Curated by Sheeba | Weedstock.com

📅 Yesterday's News & Older Articles →